Faculty Labs A-Z
New Findings Highlight Potential Treatment Aim for Heart Mutation Underlying Sudden Death
Two molecular physiologists at the University of Vermont (UVM) have taken a step closer toward a possible new treatment to address the underlying root cause of familial hypertrophic cardiomyopathy, an inherited disease that causes the heart muscle to thicken and struggle to pump blood.
Practicing Behavioral Care in an Integrated Setting: PCORI Project Ramps Up
Jen Lavoie’s daughter began showing symptoms of Crohn’s disease at age nine, but most of her clinicians found nothing wrong with her, and one suggested the girl’s gastrointestinal discomfort was “all in her head,” a symptom of stress.
Botten Team’s Research Uncovers Critical Genetic Element Driving Rodent-Hosted Virus Behavior
A team of University of Vermont researchers has pinpointed a unique self-controlling characteristic of an arenavirus that offers hope of a possible vaccine for now-untreatable infections.
Kirkpatrick and Colleagues’ Study Reveals Effective, Single-Dose Dengue Vaccine
Researchers at the University of Vermont (UVM) Vaccine Testing Center, along with collaborators at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health and Johns Hopkins Bloomberg School of Public Health, have been working since 2008 to develop a dengue vaccine that will protect against all four dengue strains.
Rincon and Thornton Discover a New Mechanism to Protect Cells in Response to DNA Breaks
Are we genetically doomed when the double helix we all identify with DNA breaks? No, say a team of researchers led by University of Vermont (UVM) immunologists, who discovered a novel mechanism that provides life support to cells while DNA double-strand break repairs are in progress.
Dostmann and Colleagues Discover Potential New Therapeutic Target for Hypertension, Earn Patent
A team of Vermont investigators has been issued a patent for their discovery of a molecule that rescues damaged blood vessels, yet preserves healthy vessels and could serve as a springboard for a new pharmaceutical therapy with fewer side effects for hypertension – a major risk factor for cardiovascular and kidney disease that effects roughly one in three people in the U.S.
Vaccine Testing Center Receives Funding to Advance New Treatments for Parasitic Infection
Limited treatment options and no vaccines exist to treat or prevent a leading cause of severe diarrhea in infants and young children in the developing world: Cryptosporidium, a single-celled intestinal parasite found in soil, food and water that also causes significant illness and death in immunocompromised individuals.
Nelson & Colleagues Join International Collaboration for Research in Prevention of Stroke and Dementia
An international consortium of institutions and investigators, including Mark Nelson, Ph.D., University of Vermont professor and chair of pharmacology, recently launched a major collaborative research program to uncover mechanisms and pathways in different forms of small vessel disease.
Cipolla Identifies Impact of Stroke-Induced Blood Substances on Healthy Vessels
Stroke – it’s the leading cause of serious long-term disability and a leading cause of death in the U.S., so figuring out how it affects the entire body is critical to identifying treatments to reduce its negative impact.
College Welcomes Jensen, Thanks Tracy, in Senior Research Dean Transition
New University of Vermont College of Medicine Senior Associate Dean for Research Gordon Jensen, M.D., Ph.D., was officially welcomed to the College at a special reception held February 4, 2016.
The Robert Larner, M.D. College of Medicine
University of Vermont
University of Vermont Medical Center
Copyright 2017 | Burlington, VT